Cerimon Pharmaceuticals
Total Raised
$72.5MInvestors Count
3Deal Terms
2Funding, Valuation & Revenue
3 Fundings
Cerimon Pharmaceuticals's latest funding round was a Unattributed VC for $1M on June 14, 2010.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
6/14/2010 | Unattributed VC | $1M | ||||
9/18/2009 | Series B | |||||
10/10/2005 | Series A |
Date | 6/14/2010 | 9/18/2009 | 10/10/2005 |
|---|---|---|---|
Round | Unattributed VC | Series B | Series A |
Amount | $1M | ||
Investors | |||
Valuation | |||
Revenue | |||
Sources |
This profile has not been claimed.
You're more than your latest funding, tell our customers your company's story.
Cerimon Pharmaceuticals Deal Terms
2 Deal Terms
Cerimon Pharmaceuticals's deal structure is available for 2 funding rounds, including their Series B from September 18, 2009.
Round | Series B | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B | |||||||||||||||
Series A |
Cerimon Pharmaceuticals Investors
3 Investors
Cerimon Pharmaceuticals has 3 investors. MPM Capital invested in Cerimon Pharmaceuticals's Unattributed VC funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
10/10/2005 | 6/14/2010 | 3 Series B, Series A (2005), Unattributed VC (2010) | Venture Capital | Massachusetts | ||
Venture Capital | New York | |||||
Investment Bank | Japan |
First funding | 10/10/2005 | ||
|---|---|---|---|
Last Funding | 6/14/2010 | ||
Investor | |||
Rounds | 3 Series B, Series A (2005), Unattributed VC (2010) | ||
Board Seats | |||
Type | Venture Capital | Venture Capital | Investment Bank |
Location | Massachusetts | New York | Japan |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.